Brain tissue oxygenation during dexmedetomidine administration in surgical patients with neurovascular injuries

Journal of Neurosurgical Anesthesiology

Volumn 22, Issue 4, 2010, Pages 336-341

  Drummond, John Cornell ^a,b   Sturaitis, Mary K ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

brain tissue PO2; cerebral blood flow; dexmedetomidine; neurologic injury; subarachnoid hemorrhage

Indexed keywords

ATENOLOL; ATORVASTATIN; DEXAMETHASONE; DEXMEDETOMIDINE; ETIRACETAM; INSULIN; LAMOTRIGINE; MAGNESIUM; MANNITOL; NIMODIPINE; PAROXETINE; PHENYTOIN; PROPOFOL; SERTRALINE; SEVOFLURANE; SUFENTANIL; THIOPENTAL;

ADULT; AGED; ARTERIOVENOUS MALFORMATION; ARTICLE; BRAIN INJURY; BRAIN TISSUE; CLINICAL ARTICLE; CONTINUOUS INFUSION; ELECTRODE; FEMALE; GENERAL ANESTHESIA; HEART RATE; HUMAN; INTRACRANIAL ANEURYSM; MALE; MEAN ARTERIAL PRESSURE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROSURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; SURGICAL PATIENT; TISSUE OXYGENATION; VASOCONSTRICTION;

ADULT; AGED; BLOOD PRESSURE; BRAIN CHEMISTRY; CEREBROVASCULAR DISORDERS; DATABASES, FACTUAL; DEXMEDETOMIDINE; FEMALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; OXYGEN CONSUMPTION; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE;

EID: 77957593704     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e3181e4b7e3     Document Type: Article

References (32)

1. Zornow MH, Fleischer JE, Scheller M.S., et al. Dexmedetomidine, an alpha 2-adrenergic agonist, decreases cerebral blood flow in the isoflurane- anesthetized dog. Anesth Analg. 1990; 70: 624-630.
2. Karlsson BR, Forsman M, Roald O.K., et al. Effect of dexmedeto-midine, a selective and potent alpha 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg. 1990; 71: 125-129.
3. McPherson RW, Kirsch JR, Traystman RJ Inhibition of nitric oxide synthase does not affect alpha 2-adrenergic-mediated cerebral vasoconstriction. Anesth Analg. 1994; 78: 67-72.
4. Fale A, Kirsch JR, McPherson RW Alpha 2-adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent. Anesth Analg. 1994; 79: 892-898.
5. Zornow MH, Maze M, Dyck J.B., et al. Dexmedetomidine decreases cerebral blood flow velocity in humans. J Cereb Blood Flow Metab. 1993; 13: 350-353.
6. Prielipp RC, Wall MH, Tobin J.R., et al. Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg. 2002; 95: 1052-1109, table of contents.
7. Drummond JC, Dao AV, Roth D.M., et al. Effect of dexmedetomi-dine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans. Anesthesiology. 2008; 108: 225-232.
8. Bekker A, Sturaitis M, Bloom M., et al. The effect of dexmedeto-midine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg. 2008; 107: 1340-1347.
9. Jodicke A, Hubner F, Boker DK Monitoring of brain tissue oxygenation during aneurysm surgery: prediction of procedure-related ischemic events. J Neurosurg. 2003; 98: 515-523.
10. 2) during aneurysm surgery. Acta Neurochir (Wien). 2002; 144: 863-886; discussion 866-7.
11. Kett-White R., Hutchinson PJ, Al-Rawi PG, et al. Cerebral oxygen and microdialysis monitoring during aneurysm surgery: effects of blood pressure, cerebrospinal fluid drainage, and temporary clipping on infarction. J Neurosurg. 2002; 96: 1013-1019.
12. Dings J, Meixensberger J, Jager A., et al. Clinical experience with 118 brain tissue oxygen partial pressure catheter probes. Neurosurgery. 1998; 43: 1082-1095.
13. Szelenyi A, Jung CS, Schon H, et al. Brain tissue oxygenation monitoring supplementary to somatosensory evoked potential monitoring for aneurysm surgery. Initial clinical experience. Neurol Res. 2002; 24: 555-562.
14. Ishiyama T, Dohi S, Iida H., et al. Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg. 1995; 81: 1208-1215.
15. Asano Y, Koehler RC, Kawaguchi T, et al. Pial arteriolar constriction to alpha 2-adrenergic agonist dexmedetomidine in the rat. Am J Physiol. 1997; 272: H2547-H2556.
16. Wagerle LC, Delivoria-Papadopoulos M. Alpha-adrenergic receptor subtypes in the cerebral circulation of newborn piglets. Am J Physiol. 1987; 252: R1092-R1098.
17. Ayajiki K, Toda N. Isolated bovine cerebral arteries from rostral and caudal regions: distinct responses to adrenoceptor agonists. Eur J Pharmacol. 1990; 191: 417-425.
18. Toda N. Alpha adrenergic receptor subtypes in human, monkey and dog cerebral arteries. J Pharmacol Exp Ther. 1983; 226: 861-868.
19. Sturaitis MK, Moore LE, Kirsch J.R., et al. A cholinergic agonist induces hyperemia in isoflurane- but not pentobarbital-anesthetized dogs. Anesth Analg. 1994; 78: 876-883.
20. Bari F, Horvath G, Benedek G. Dexmedetomidine-induced decrease in cerebral blood flow is attenuated by verapamil in rats: a laser Doppler study. Can J Anaesth. 1993; 40: 748-754.
21. Roekaerts PM, Lawrence CJ, Prinzen F.W., et al. Alleviation of the peripheral hemodynamic effects of dexmedetomidine by the calcium channel blocker isradipine. Acta Anaesthesiol Scand. 1997; 41: 364-370.
22. Patel PM, Drummond JC Cerebral Physiology and the Effects of Anesthetic Agents and Techniques. In: Miller RD, ed. Miller's Anesthesia. Philadelphia: Lippincott, Williams and Wilkens; 2010: 305-339, Chapter 13.
23. Wolff DJ, Datto GA, Samatovicz R.A., et al. Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles. J Biol Chem. 1993; 268: 9425-9429.
24. Drummond JC, Cole DJ, Patel P.M., et al. Focal cerebral ischemia during anesthesia with etomidate, isoflurane or thiopental: a comparison of the extent of cerebral injury. Neurosurgery. 1995; 37: 742-749.
25. Hoffman WE, Charbel FT, Edelman G, et al. Comparison of the effect of etomidate and desflurane on brain tissue games and pH during prolonged middle cerebral artery occlusion. Anesthesiology. 1998; 88: 1188-1194.
26. Drummond JC, McKay LD, Cole D.J., et al. The role of nitric oxide synthase inhibition in the adverse effects of etomidate in the setting of focal cerebral ischemia in rats. Anesth Analg. 2005; 100: 841-846.
27. Nakano T, Okamoto H. Dexmedetomidine-induced cerebral hypo-perfusion exacerbates ischemic brain injury in rats. J Anesth. 2009; 23: 378-384.
28. Hoffman WE, Charbel FT, Edelman G, et al. Brain tissue oxygenation in patients with cerebral occlusive disease and arteriovenous malformations. Br J Anaesth. 1997; 78: 169-171.
29. Tijero T, Ingelmo I, Garcia-Trapero J, et al. Usefulness of monitoring brain tissue oxygen pressure during awake craniotomy for tumor resection: a case report. J Neurosurg Anesthesiol. 2002; 14: 149-152.
30. Chen HI, Malhotra NR, Oddo M, et al. Barbiturate infusion for intractable intracranial hypertension and its effect on brain oxygenation. Neurosurgery. 2008; 63: 880-886; discussion 886-7.
31. Martini RP, Deem S, Yanez N.D., et al. Management guided by brain tissue oxygen monitoring and outcome following severe traumatic brain injury. J Neurosurg. 2009; 111: 644-649.
32. Bekker A, Sturaitis MK Dexmedetomidine for neurological surgery. Neurosurgery. 2005; 57(SUPPL. 1): 1-10; discussion 1-10.